Evidence map›Paper›PMID 25010359›Full record

ArticleJAMA ophthalmology2014

Adalimumab for pediatric sympathetic ophthalmia.

Joon-Bom Kim, Abdallah Jeroudi, Sheila T Angeles-Han, Hans E Grossniklaus, Steven Yeh

Abstract readCase Reports
In one paragraph

Article in JAMA ophthalmology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Sympathetic ophthalmia: A comprehensive update.Indian journal of ophthalmology · 2022
    Review
  5. Review
  6. Article
  7. An Update on Treatment of Pediatric Chronic Non-Infectious Uveitis.Current treatment options in rheumatology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Joon-Bom KimEmory Eye Center, Department of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia.
Abdallah JeroudiEmory Eye Center, Department of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia.
Sheila T Angeles-HanEmory Eye Center, Department of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia2Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia3Children's Hospital of Atlanta, Atlanta, Georgia.
Hans E GrossniklausEmory Eye Center, Department of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia.
Steven YehEmory Eye Center, Department of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia.
Emory University · USEmory Eye Center · US

Funding

P30-Core Grant for Vision Research Core CP30EY006360 · NEI · EMORY UNIVERSITY · PI GEISERT, ELDON E · 1986 to 2025
$15.3M
Outcomes of children with juvenile idiopathic arthritis-associated uveitisK23EY021760 · NEI · EMORY UNIVERSITY · PI ANGELES-HAN, SHEILA THERESE · 2011 to 2015
$980k
NEI NIH HHS K23 EY021760NEI NIH HHS P30 EY006360
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdalimumabAntibodies, Monoclonal, HumanizedFemaleHumansOphthalmia, SympatheticTumor Necrosis Factor-alphaAdalimumabAntibodies, Monoclonal, HumanizedTumor Necrosis Factor-alpha

Identifiers

PMID25010359
PMCPMC4976083
OpenAlexW1986208828

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.